BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2006
View Archived Issues
Axcan updates clinical progress
Read More
COX-2 NSAIDs target tNOX tumor-selectively in their anticancer activity / News in Context
Read More
Radiotracers allow for assessment of neuropathology in AD
Read More
Enrollment completed in phase II/III study of MN-305 for GAD
Read More
Boehringer Ingelheim closes treatment arm in Aptivus study
Read More
Procyon shareholders approve Cellpep acquisition
Read More
MorphoSys updates development strategy
Read More
Second phase III trial under way for alfimeprase in catheter occlusion
Read More
CHF-1512 superior to standard levodopa/carbidopa in Parkinson's disease patients
Read More
Phase I and II studies assess velafermin in oral mucositis
Read More
Rotigotine receptor profile, effects in Parkinson's disease model reported
Read More
Combined RESIST-1 and RESIST-2 data reveal efficacy of tipranavir plus ritonavir
Read More
Mobilization of hematopoietic stem cells increased with AMD-3100
Read More
SM-360320: targeting TLR7 for HCV therapy
Read More
New phase I/II study evaluates MyVax personalized immunotherapy for CLL
Read More
AMDL's DR-70 cancer test kit shows efficacy as tumor marker for ovarian cancer
Read More
New phase I study for NGX-267 for Alzheimer's disease
Read More
PC-DAC:Exendin-4 cleared for phase I/II study in type 2 diabetes
Read More
Transition Therapeutics to acquire outstanding shares of Ellipsis Neurotherapeutics
Read More
Chiron updates status of H5N1 avian influenza vaccine contracts
Read More
DPP-IV inhibitor GRC-8200 well tolerated in phase I study
Read More
TP-10 shows no significant efficacy in female cardiac bypass surgery patients
Read More
New therapeutics for cancer disclosed in recent patent literature
Read More
FDA approval for Zegerid Capsules
Read More
Emsam approved for major depressive disorder
Read More
U.S. approval for Rituxan in active rheumatoid arthritis
Read More
Compounds with potential applicability in neurological disorders patented
Read More
Novel antiplatelet agents claimed in recent Daiichi patent
Read More
New data on rPA anthrax vaccine presented
Read More
Lassa fever vaccine may protect against all strains of Lassa virus
Read More